Delivery Order SPE2DB22D3301-SPE2DB25FY7QB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with delivery to be completed by August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on August 7, 2025. The product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $2,060.62 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes on October 21, 2025, with completion scheduled for November 12, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. RhoGAM is an immunoglobulin...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes valued at $1,821.20 under a firm fixed price contract. The award was made on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-set-aside delivery order represents a small-value pharmaceutical transaction typical of federal medical procurement operations supporting military and defense healthcare systems. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,906.60 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order, issued on November 20, 2025, represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.72 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes. This competitively awarded, firm fixed-price delivery order was issued on September 4, 2025, with an ultimate completion date of September 25, 2025. The product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,954.04 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for Rhogam Ultra-Filtered Plus syringes, with an ultimate completion date of July 22, 2025. This non-set-aside contract is being performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and holds an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,325.28 delivery order contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a period of performance through October 4, 2023. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,731.80, is a Firm Fixed Price Delivery Order for the supply of Rhogam Ultra-Filtered Plus Syrs, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award, valued at $2,832.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a completion date of July 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the federal government - one with the DLA Troop Support Medical valued up to...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $3,824.00 delivery order by the Defense Logistics Agency on September 11, 2025, for the supply of Rhophylac 300 micrograms per 2 milliliter syringes. This is a competitively awarded, non-set-aside contract utilizing firm fixed pricing, with an ultimate completion date of October 2, 2025. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY7QBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with performance to be completed by July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. No set-aside designation was applied to this award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this pharmaceutical supply delivery. This delivery order falls within AmerisourceBergen's extensive portfolio of federal medical procurement contracts supporting military and veteran healthcare systems. The company leverages its comprehensive IDC with DLA to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen consistently fulfills delivery orders through open competition, demonstrating its capability to meet the Defense Logistics Agency's medical supply chain requirements for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/10/25 |